Vaccines for cancer and several other diseases might be ready as early as 2030 thanks to 15 years of progress that has “unwound” in 12 to 18 months for the COVID-19 vaccine, according to a major pharmaceutical company.
Pharmaceutical firm Moderna has estimated that it will be able to offer vaccines for ‘all sorts of different diseases’ in as little as 5 years, according to Dr.r Paul Burton, chief medical officer of the pharmaceutical company, to the English media The Guardian SATURDAY.
Cancer, cardiovascular diseases, autoimmune diseases, rare diseases: studies on these vaccinations, which might save thousands – even millions – of lives, would thus prove “extremely promising”, according to him.
“What we have learned in the last few months […] is that they can be applied to all kinds of diseases […] We have studies in all of these areas and they have all shown to be extremely promising,” he said.
Some researchers, such as Dr Richard Hackett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI), also applauds the 15 years of progress made in a few months during the race for the COVID vaccine, continued the British media.
Right now, the pharmaceutical firm that developed one of the leading COVID vaccines is reportedly working on vaccines that target different tumors.
“I think we will be able to offer personalized vaccines once morest cancer and several different types of tumors to people all over the world,” added Dr.r Burton.
These personalized vaccines would be created from a patient’s own genetic material, to target and combat the exact mutation that is causing the tumor in the body.
According to the chief medical officer, the company would also be able to create vaccines containing several respiratory infections, such as influenza, COVID and respiratory syncytial virus (RSV), in a single injection for vulnerable people.
